Ophthalmic Viscoelastic Devices Market Report 2025

The ophthalmic viscoelastic devices market size has grown steadily in recent years. It will grow from $2.65 billion in 2024 to $2.75 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to a rise in cataract surgeries, advancements in ophthalmic surgery techniques, aging population demographics, increased incidence of eye disorders, and increased patient awareness and access to eye care.

The ophthalmic viscoelastic devices market size is expected to see strong growth in the next few years. It will grow to $3.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to technological refinements in device design, expanding applications in eye surgery, rising demand for premium intraocular lenses, global efforts in eye health and vision care, market penetration in emerging economies, collaborations, and training programs in ophthalmology. Major trends in the forecast period include customized ophthalmic solutions, regulatory compliance and quality assurance, collaborations and partnerships, patient preference for premium products, and continuous research and development.

The increasing prevalence of cataracts and glaucoma is anticipated to drive growth in the ophthalmic viscoelastic devices (OVD) market. Cataracts involve the clouding of the eye lens, leading to diminished vision, while glaucoma comprises a set of eye conditions that damage the optic nerve, often due to elevated eye pressure, potentially resulting in vision loss or blindness if untreated. Ophthalmic viscoelastic devices, gel-like substances, are commonly used in eye surgeries such as cataract operations and specific glaucoma procedures. For example, as reported by the BrightFocus Foundation, a US-based nonprofit organization, there were 80 million glaucoma cases globally as of October 2022, with projections estimating an increase to nearly 111 million by 2040. Consequently, the rising incidence of cataracts and glaucoma is fueling the expansion of the ophthalmic viscoelastic devices market.

The rise in the number of ophthalmic surgeries is expected to propel the growth of the ophthalmic viscoelastic devices market. OVDs play a crucial role in various eye surgeries, maintaining space, protecting delicate eye structures, and aiding surgical maneuvers due to their unique gel-such as properties. For instance, cataract surgery, constituting 6% of total surgeries in England, is anticipated to increase by 25% by 2027 and by 50% by 2035, according to the National Health Service. This surge in surgeries showcases the growing demand for ophthalmic viscoelastic devices in ensuring successful outcomes and reducing complications in eye surgeries.

Innovations in product offerings are becoming a prominent trend in the ophthalmic viscoelastic devices market, as companies introduce advanced technologies to maintain market presence. For example, Bausch + Lomb Corporation introduced the StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System in April 2023. These products, containing unique chemical compounds such as sodium hyaluronate and sorbitol, enhance surgical precision and offer improved protection to ocular tissues. Furthermore, major players in the market are focused on technological advancements such as implant-free systems to enhance surgical precision and patient outcomes in ophthalmic surgeries.

Prominent companies operating in the ophthalmic viscoelastic devices market prioritize technological advancements, particularly in line implant-free system solutions. Cutting-edge technologies such as the STREAMLINE surgical system, launched by New World Medical Inc. in March 2022, integrate ClickPulse Technology to offer implant-free solutions. This advanced system facilitates precise surgical procedures without invasive implants, presenting versatile applications in ophthalmic surgeries. The technology allows for precision in creating goniotomies and administering minimal quantities of ophthalmic viscosurgical devices directly into the canal of Schlemm, augmenting surgical efficiency and patient outcomes.

In January 2024, the Netherlands-based pharmaceutical company Nordic Group B.V. acquired Visant Medical, Inc. for an undisclosed sum. This acquisition allows Nordic Group B.V. to enhance its portfolio in the global ophthalmology market and expand its commercialization and development of specialized products across therapeutic areas within ophthalmology. Visant Medical, Inc., a U.S.-based company, focuses on the development of innovative medical devices for ophthalmic applications.

Major companies operating in the ophthalmic viscoelastic devices market include Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc., Eyekon Medical Inc., Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Ophtechnics Unlimited, Truviz Ophthalmic, Beye LLC, Alcon Inc., Beaver Visitec Limited, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., OcuCo Ltd., Precision Lens Co. Ltd., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.

North America was the largest region in the ophthalmic viscoelastic devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic viscoelastic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ophthalmic viscoelastic devices (OVDs) are gel-such as substances utilized in specific eye surgeries to establish and maintain intraocular space, safeguard delicate eye structures, and aid in surgical maneuvers. These substances typically possess a clear, viscous, and elastic nature, mimicking the properties of natural fluids found within the eye.

The primary categories of OVDs are cohesive ophthalmic viscoelastics and dispersive ophthalmic viscoelastics. Cohesive ophthalmic viscoelastics are highly viscous and cohesive, maintaining their form as a single mass rather than dispersing within the eye. They are predominantly employed in cataract surgery but also find application in procedures such as glaucoma surgery, corneal transplant, and vitreoretinal surgery. These substances are utilized by various entities, including hospitals, ophthalmology clinics, and similar medical facilities.

The ophthalmic viscoelastic devices market research report is one of a series of new reports that provides ophthalmic viscoelastic devices market statistics, including ophthalmic viscoelastic devices industry global market size, regional shares, competitors with an ophthalmic viscoelastic devices market share, detailed ophthalmic viscoelastic devices market segments, market trends, and opportunities, and any further data you may need to thrive in the ophthalmic viscoelastic devices industry. The ophthalmic viscoelastic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ophthalmic viscoelastic devices market consists of sales of cohesive OVDs, dispersive OVDs, and combined OVDs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.